19 /100
LOW RISK
Score updated May 29, 2026

SNDX — Syndax Pharmaceuticals, Inc. Dilution Risk Tracker

Track SNDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNDX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SNDX.
🔔 Track SNDX — Get forecast alerts →

💹 Market Data

Market Cap$1.75B
Shares Outstanding88.61M
Float79.03M
Cash$361.24M
Debt$345.36M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.4% shares (2025Q4 vs prior)
232 institutional holders · 106.56M shares
#1 BANK OF AMERICA CORP /DE/ 8.41M shares
#2 BlackRock, Inc. 8.24M shares
#3 Kynam Capital Management, LP 8.05M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest19.91M
Days to Cover12.7
% of Float25.2%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2019
xbrl XBRL CONVERTIBLE Dec 31, 2016
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SNDX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNDX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SNDX
📊 SNDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SNDX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.